References
- Schultz, KR., Massing, B., Spinelli, J.J., Gaynon, P.S. and Wadsworth, L. (1997) "Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia", Medical and Pediatric Oncology, 29, 16–22.
- Gaynon, P.S. (2000) "Prognostic factors in acute lymphoblastic leukemia", Journal of Pediatric Hematology/Oncology, 22, 403–404.
- Pui, C-H. (2001) "Risk assessment in acute lymphoblastic leukemia: beyond leukemia cell characteristics", Journal of Pediatric Hematol-ogy/Oncology, 23, 405 —408.
- Kidd, PG., Saminathan, T., Drachtman, R.A. and Ettinger, L.J. (1997) "Comparison of the cellularity and presence of residual leukemia in bone marrow aspirate and biopsy specimens in pediatric patients with acute lymphoblastic leukemia (ALL) at Day 7–14 of chemotherapy", Medical and Pediatric Oncology, 29, 541–543.
- Coustan-Smith, E., Sancho, J., Hancock, ML., Boyett, J.M., Behm, F.G., Raimondi, S.C., et al. (2000) "Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia", Blood, 96, 2691–2696.
- Steinherz, PG., Gaynon, P.S., Breneman, J.C., Cherlow, J.M., Grossman, N.J., Kersey, J.H., et al. (1996) "Cytoreduction and prognosis in acute lymphoblastic leukemia—the importance of early marrow response: Report from the Children's Cancer Group", Journal of Clinical Oncology, 14, 389 — 398.
- Gruppo, R.A., Lampkin, B.C. and Granger, S. (1977) "Bone marrow cellularity determination: comparison of the biopsy, aspirate, and buffy coat", Blood, 49, 29–31.